These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The pathway by which the tetrameric protein transthyretin dissociates. Foss TR; Wiseman RL; Kelly JW Biochemistry; 2005 Nov; 44(47):15525-33. PubMed ID: 16300401 [TBL] [Abstract][Full Text] [Related]
3. Water Plays Key Roles in Stabilities of Wild Type and Mutant Transthyretin Complexes. Lantz C; Rider RL; Yun SD; Laganowsky A; Russell DH J Am Soc Mass Spectrom; 2024 Aug; 35(8):1854-1864. PubMed ID: 39057193 [TBL] [Abstract][Full Text] [Related]
4. Characterization of the transthyretin acid denaturation pathways by analytical ultracentrifugation: implications for wild-type, V30M, and L55P amyloid fibril formation. Lashuel HA; Lai Z; Kelly JW Biochemistry; 1998 Dec; 37(51):17851-64. PubMed ID: 9922152 [TBL] [Abstract][Full Text] [Related]
5. Retinol and retinol-binding protein stabilize transthyretin via formation of retinol transport complex. Hyung SJ; Deroo S; Robinson CV ACS Chem Biol; 2010 Dec; 5(12):1137-46. PubMed ID: 20845945 [TBL] [Abstract][Full Text] [Related]
6. Structural insight into pH-induced conformational changes within the native human transthyretin tetramer. Palaninathan SK; Mohamedmohaideen NN; Snee WC; Kelly JW; Sacchettini JC J Mol Biol; 2008 Oct; 382(5):1157-67. PubMed ID: 18662699 [TBL] [Abstract][Full Text] [Related]
7. Initial conformational changes of human transthyretin under partially denaturing conditions. Yang M; Lei M; Bruschweiler R; Huo S Biophys J; 2005 Jul; 89(1):433-43. PubMed ID: 15821170 [TBL] [Abstract][Full Text] [Related]
8. Exploration of the Misfolding Mechanism of Transthyretin Monomer: Insights from Hybrid-Resolution Simulations and Markov State Model Analysis. Zhou S; Cheng J; Yang T; Ma M; Zhang W; Yuan S; Lo GV; Dou Y Biomolecules; 2019 Dec; 9(12):. PubMed ID: 31861226 [TBL] [Abstract][Full Text] [Related]
10. Guanidine hydrochloride-induced denaturation and refolding of transthyretin exhibits a marked hysteresis: equilibria with high kinetic barriers. Lai Z; McCulloch J; Lashuel HA; Kelly JW Biochemistry; 1997 Aug; 36(33):10230-9. PubMed ID: 9254621 [TBL] [Abstract][Full Text] [Related]
11. Transthyretin aggregation under partially denaturing conditions is a downhill polymerization. Hurshman AR; White JT; Powers ET; Kelly JW Biochemistry; 2004 Jun; 43(23):7365-81. PubMed ID: 15182180 [TBL] [Abstract][Full Text] [Related]
12. Surface-Induced Dissociation of Homotetramers with D2 Symmetry Yields their Assembly Pathways and Characterizes the Effect of Ligand Binding. Quintyn RS; Yan J; Wysocki VH Chem Biol; 2015 May; 22(5):583-92. PubMed ID: 25937312 [TBL] [Abstract][Full Text] [Related]
13. The sequence-dependent unfolding pathway plays a critical role in the amyloidogenicity of transthyretin. Yang M; Yordanov B; Levy Y; Brüschweiler R; Huo S Biochemistry; 2006 Oct; 45(39):11992-2002. PubMed ID: 17002298 [TBL] [Abstract][Full Text] [Related]
15. L55P transthyretin accelerates subunit exchange and leads to rapid formation of hybrid tetramers. Keetch CA; Bromley EH; McCammon MG; Wang N; Christodoulou J; Robinson CV J Biol Chem; 2005 Dec; 280(50):41667-74. PubMed ID: 16219761 [TBL] [Abstract][Full Text] [Related]
16. Kinetic stabilization of the native state by protein engineering: implications for inhibition of transthyretin amyloidogenesis. Foss TR; Kelker MS; Wiseman RL; Wilson IA; Kelly JW J Mol Biol; 2005 Apr; 347(4):841-54. PubMed ID: 15769474 [TBL] [Abstract][Full Text] [Related]
17. An engineered transthyretin monomer that is nonamyloidogenic, unless it is partially denatured. Jiang X; Smith CS; Petrassi HM; Hammarström P; White JT; Sacchettini JC; Kelly JW Biochemistry; 2001 Sep; 40(38):11442-52. PubMed ID: 11560492 [TBL] [Abstract][Full Text] [Related]
18. Surface-Induced Dissociation Mass Spectra as a Tool for Distinguishing Different Structural Forms of Gas-Phase Multimeric Protein Complexes. Quintyn RS; Zhou M; Yan J; Wysocki VH Anal Chem; 2015 Dec; 87(23):11879-86. PubMed ID: 26499904 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and characterization of potent bivalent amyloidosis inhibitors that bind prior to transthyretin tetramerization. Green NS; Palaninathan SK; Sacchettini JC; Kelly JW J Am Chem Soc; 2003 Nov; 125(44):13404-14. PubMed ID: 14583036 [TBL] [Abstract][Full Text] [Related]
20. Trapping the monomer of a non-amyloidogenic variant of transthyretin: exploring its possible use as a therapeutic strategy against transthyretin amyloidogenic diseases. Palhano FL; Leme LP; Busnardo RG; Foguel D J Biol Chem; 2009 Jan; 284(3):1443-53. PubMed ID: 18984591 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]